7-(phenylsulfonylmethyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine

ID: ALA1077578

PubChem CID: 46882673

Max Phase: Preclinical

Molecular Formula: C17H19NO2S

Molecular Weight: 301.41

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=S(=O)(Cc1ccc2c(c1)CCNCC2)c1ccccc1

Standard InChI:  InChI=1S/C17H19NO2S/c19-21(20,17-4-2-1-3-5-17)13-14-6-7-15-8-10-18-11-9-16(15)12-14/h1-7,12,18H,8-11,13H2

Standard InChI Key:  ICKFLQAGATZMFM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -4.6584   -0.1795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3757    0.2298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0890   -0.1864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0843   -1.0148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3680   -1.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6545   -1.0017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9460    0.2382    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2244    2.3047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2257    1.4803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5070    1.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5090    2.7182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0055    1.8884    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3503    2.6358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1536    2.8194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3524    1.1479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1568    0.9649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7977    1.4826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7987    2.3087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9465    1.0636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2366    0.6565    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5396   -0.4729    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 18 11  2  0
 11  8  1  0
  5  6  2  0
  6  1  1  0
  1  2  2  0
  3  4  2  0
  8  9  2  0
  4  5  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
 15 16  1  0
  9 10  1  0
  9 19  1  0
 19  7  1  0
  7  1  1  0
 10 17  2  0
  7 20  2  0
  2  3  1  0
  7 21  2  0
M  END

Associated Targets(Human)

GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MLNR Tchem Motilin receptor (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 301.41Molecular Weight (Monoisotopic): 301.1136AlogP: 2.35#Rotatable Bonds: 3
Polar Surface Area: 46.17Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.86CX LogP: 2.58CX LogD: 0.18
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.95Np Likeness Score: -1.04

References

1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM..  (2009)  The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.,  19  (22): [PMID:19804969] [10.1016/j.bmcl.2009.09.027]

Source